Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04257045 · ClinicalTrials.gov registry record
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 46
- Enrollment target
NCT04257045: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT04257045 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04257045 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
This trial collects information about factors that affect communication of genetic test results, decision-making, and access to genetic testing in women with hereditary gynecological cancers. Studying individuals who are positive for a genetic mutation and immediate biological family members (including a parent, full-sibling, or child) may help identify cancer genes and other persons at risk.
Interventions
- OTHER Survey Administration
- OTHER Questionnaire Administration
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2019-08-21 |
| Est. Completion | 2024-07-09 |
What the finished NCT04257045 record still lists
NCT04257045 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT04257045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04257045 about?
NCT04257045 is a clinical study titled "Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives". This trial collects information about factors that affect communication of genetic test results, decision-making, and access to genetic testing in women with hereditary gynecological cancers. Studying individuals who are positive for a genetic mutation and immediate biological family members (includ...
What is the current status of trial NCT04257045?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2019-08-21. Estimated completion is 2024-07-09.
What interventions are being tested in trial NCT04257045?
The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT04257045?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI